低分子量肝素的研究进展
作者：曹鉴平,胡志洁
Author：
收稿日期： 年卷（期）页码：2003,(01):-35-38
期刊名称：华西药学杂志
Journal Name：WEST CHINA JOURNAL OF PHARMACEUTICAL SCIENCES
关键字：低分子量肝素;药理作用;临床应用
Key words：
基金项目：
中文摘要
综述了低分子量肝素在国内外的最新研究、药理作用及其最新应用现状。
参考文献
1 ThamesBC ,AllenDO .AANAJournalcourse:updatefornursean-esthetists-lowmolecularweightheparin:pharmacologyandregionalanes thetic[J].AANAJ,2000,68(4):357
2 CapriniJA ,ArcelusJ,SehgalLR ,etal.Theuseoflowmolecularweightheparinsforthepreventionofpostoperativevenousthromboembotismingeneralsurgery.ASurveyofpracticeintheUnitedStates[J].IntAngiol,2002,21(1):78
3 BreddinHK .Reviparinsodium-anewlowmolecularweightheparin[J].ExpertOpinPharmacother,2002,3(2):173
4 FareedJ,HoppensteadtDA .Pharmacologyofthelow-molecular-weightheparin[J].SeminThrombHemost,1996,22(suppl2):13
5 LiY ,ShinVY ,CheukCY ,etal.A 3.0-KDalowmolecularweighthep arinpromotesgastriculcerhealinginrats[J].AlimentPharmacolTher,2001,15(12):2009
6 JonasS ,SugimoriM ,LlinasR .Islowmolecularweightheparinaneuropro tectant[J].AnnNYAcadSci,1997,825:389
7 WanMX ,ZhangXW ,TorkvistL ,etal.Lowmolecularweighthearinin hibitstumornecrosisfactoralpha-inducedleukocyterolling[J].InflammRex,2001,50(12):58
8 BaramD ,RashkovskyM ,HershkovizR ,etal.Inhibitoryeffectsflowmolecularheparinonmediatorreleasebymastcells:preferentialinhibitionofcytokineproductionandmastcell-dependentcutaneousinflammation[J].ClinExpImmunol,1997,110(3):485
9 SchwartzD ,EngelhardD ,GallilyR ,etal.Clialcellsproductionofinflam matorymediatorsinducedbyStreptococcuspneumoniae:inhibitionbypen toxifylline,low-molecular-weightheparinanddexamethasone[J].JNeurolSci,1998,155(1):13
10张澍,徐飞,徐伟,等低分子量肝素治疗不稳定型心绞痛[J]中国临床医学,2001,8(2):168
11封金伟,吕艳青,张向东低分子量肝素钙治疗不稳定心绞痛的疗效观察[J]中国综合临床,2001,17(1):17
12吕辰依诺肝素治疗冠状动脉疾病的临床潜力[J]ForeignMedi calSciencesSectiononPharmacy,1999,26(4):210
13李晓红,乔李静,黄萍,等脑梗死患者凝血、抗凝、纤溶指标改变及低分子量肝素治疗研究[J].中华老年心脑血管病杂志,2001,3(4):244
14王振才,王廷瑞,于福恩,等低分子量肝素治疗急性脑血管病研究[J]中国综合临床,2001,17(2):99
15CyrkowiczA .Redutioninfatalpulmonaryembolismandvenousthrombo sisbyperioperativeadministratonoflowmolecularweightheparin.Gyne cologicalwordretrospectiveanalysis[J].EurJObstetGynecolReprodBi ol,2002,100(2):223
16ChengX ,HeJ,GaoM ,etal.Multicenterclinicaltrialontheefficacyofthrombolytictherapywithurokinaseand/oranticoagulantwithlowmolec ularweightheparininacutepulmonaryembolism[J].ZhonghuaNeiKeZaZhi,2002,41(1):6
17MismettiP ,Laporte-SimitsidisS ,TardyB ,etal.Preventionofvenousthromboembolismininternalmedicinewithunfractionatedorlow-molec ular-weightheparins:ameta-analysisofrandomizedclinicaltrials[J].ThrombHaemost,2000,83(1):14
18陈锦海,黄荣桂低分子量肝素治疗原发性肾病综合征疗效观察[J]福建医药杂志,2001,23(3):104
19林志翔,梅长林,张翼翔,等低分子量肝素治疗原发性肾病综合征高凝状态疗效观察[J]中国实用内科杂志,1999,19(2):89
20DotanI,HallakA ,ArberN ,etal.Low-doselow-molecularweightheparin(enoxaparin)iseffectiveasadjuvanttreatmentinactiveulcerativecolitis:anopentrial[J].DigDisSci,2001,46(10):2239
21李介秋,张开诚,吕新生低分子量肝素治疗重症急性胰腺炎[J]中国普通外科杂志2001,10(4):296
22DentonCP ,HowellK ,StrattonRJ,etal.Long-termlowmolecularweightheparintherapforsevereRaynaud’sphenomenon:apilotstudy[J].ClinExpRheumatol,2000,18(4):499
23诸青低分子量肝素在血液透析高危出血倾向患者中的应用[J]内科急危重症杂志,2001,7(1):35
【关闭】
